Investing Profile

Graziano Seghezzi

InvestorVC
Managing Partner at Sofinnova Partners
Photo of Graziano Seghezzi, Managing Partner at Soffinova Partners
cb
Soffinova Partners Managing Partner
$100K - $5.0M
$1.5M
36
$548M
CompanyStageDateRound SizeTotal Raised
MISSION Therapeutics
Series DMar 2024$32M
Series CJul 2020$15M
Series CFeb 2016$86M
Series BNov 2013$32M
Series AAug 2011$6M
$170M
Co-investors: Denis Patrick (Pfizer Venture Investments), Deborah Harland (SR One)
GlycoEra
Series AJan 2024
Series ANov 2021$49M
$49M
Co-investors: Mira Chaurushiya (Westlake Village BioPartners), Monique Schiersing (Roche Venture Fund)
T-Therapeutics
Series ANov 2023$60M
$60M
Co-investors: Nihal Sinha (F-Prime Capital Partners), Robert Tansley (Cambridge Innovation Capital), Samuel Bjork (Digitalis Ventures)
Tenpoint Therapeutics
Series AJul 2023$70M
$70M
Co-investors: Alexander Pasteur (F-Prime Capital Partners)
AAVantgarde Bio
Series AJun 2023$65M
SeedJun 2021
$65M
Co-investors: Dmitrij Hristodorov (Forbion), David Steinberg (Longwood Fund), Paola Pozzi (Soffinova Partners), Jason Rhodes (Atlas Venture)
Alia Therapeutics
SeedApr 2023$5M
SeedJun 2021
$6M
Co-investors: Paola Pozzi (Soffinova Partners), Gabriella Camboni (Soffinova Partners)
Mablink Bioscience
Series AOct 2022$30M
$30M
HotSpot Therapeutics
Series CNov 2021$100M
Series BMay 2020$65M
Series AJul 2018$45M
SeedMar 2017
$210M
Co-investors: Fouad Azzam (EQT Life Sciences), Jill carroll (SR One), Bruce Booth (Atlas Venture), Ash Khanna (Pivotal bioVenture Partners)